/APYX
APYX Stock - Apyx Medical Corporation
Healthcare|Medical - DevicesNASDAQ
$3.49-5.93%
$0.22 (-5.93%) • Dec 19
76
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.BUY
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.74
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).100
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.61
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+71.9%upside
Target: $6.00
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for APYX
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$3.46 – $3.52
TARGET (TP)$6.00
STOP LOSS$3.21
RISK/REWARD1:9.0
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta1.49
52W High$4.44
52W Low$0.76
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $48.10M | $52.35M | $44.51M | $48.52M | $27.71M |
| Gross Profit | $29.36M | $33.76M | $29.13M | $33.60M | $17.50M |
| Gross Margin | 61.0% | 64.5% | 65.4% | 69.3% | 63.2% |
| Operating Income | $-18,845,000 | $-17,259,000 | $-23,562,000 | $-14,448,000 | $-20,083,000 |
| Net Income | $-23,463,000 | $-18,713,000 | $-23,184,000 | $-15,172,000 | $-11,896,000 |
| Net Margin | -48.8% | -35.7% | -52.1% | -31.3% | -42.9% |
| EPS | $-0.66 | $-0.54 | $-0.67 | $-0.44 | $-0.35 |
Company Overview
Apyx Medical Corporation, an energy technology company, develops, manufactures, and sells medical devices in the cosmetic and surgical markets worldwide. The company operates in two segments, Advanced Energy and Original Equipment Manufacturing (OEM). It offers Helium Plasma Generator for delivery of RF energy and helium to cut, coagulate and ablate soft tissue during open and laparoscopic surgical procedures. The company offers Renuvion branded products for the cosmetic surgery market that enable plastic surgeons, fascial plastic surgeons, and cosmetic physicians to provide controlled heat to the tissue to achieve their desired results; and J-Plasma branded products for the hospital surgical market. It also develops, manufactures, and sells disposable hand pieces, and OEM generators and accessories. The company was formerly known as Bovie Medical Corporation and changed its name to Apyx Medical Corporation in January 2019. Apyx Medical Corporation was incorporated in 1982 and is based in Clearwater, Florida.
Visit WebsiteRating Distribution
Strong Buy
0%
Buy / Outperform
4
80%
Hold / Neutral
1
20%
Sell / Underperform
0%
Analyst Consensus🟢 Bullish
4 Bullish1 Neutral/Bearish
Price Targets
$9
Average Target
↑ 143.6% Upside
Now
$6
Low
$9
Average
$12
High
Based on 4 analysts
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| December 16th 2025 | Roth Capital | Initiation | Buy | $6 |
| November 14th 2025 | Citizens JMP | Upgrade | Mkt Outperform | - |
| November 12th 2025 | Citizens JMP | Upgrade | Mkt Outperform | $8 |
| October 17th 2024 | BTIG Research | Initiation | Neutral | - |
| July 14th 2023 | Stephens | Initiation | Overweight | $8 |
| May 20th 2022 | Lake Street | Initiation | Buy | $12 |
Earnings History & Surprises
APYXBeat Rate
56%
Last 18 quarters
Avg Surprise
-16.5%
EPS vs Estimate
Beats / Misses
10/8
Last 12 quarters
Latest EPS
$-0.05
Q4 2025
EPS Surprise History
Q1 24
-46.2%
$-0.19vs$-0.13
Q2 24
-22.2%
$-0.22vs$-0.18
Q3 24
-5.6%
$-0.19vs$-0.18
Q4 24
+6.7%
$-0.14vs$-0.15
Q1 25
+7.7%
$-0.12vs$-0.13
Q2 25
+16.7%
$-0.10vs$-0.12
Q3 25
+3.6%
$-0.09vs$-0.09
Q4 25
+16.7%
$-0.05vs$-0.06
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2026 | May 6, 2026 | — | — | — | — |
Q1 2026 | Mar 12, 2026 | $-0.06 | — | — | — |
Q4 2025 | Nov 6, 2025 | $-0.06 | $-0.05 | +16.7% | ✓ BEAT |
Q3 2025 | Aug 7, 2025 | $-0.09 | $-0.09 | +3.6% | ✓ BEAT |
Q2 2025 | May 8, 2025 | $-0.12 | $-0.10 | +16.7% | ✓ BEAT |
Q1 2025 | Mar 13, 2025 | $-0.13 | $-0.12 | +7.7% | ✓ BEAT |
Q4 2024 | Nov 8, 2024 | $-0.15 | $-0.14 | +6.7% | ✓ BEAT |
Q3 2024 | Aug 8, 2024 | $-0.18 | $-0.19 | -5.6% | ✗ MISS |
Q2 2024 | May 9, 2024 | $-0.18 | $-0.22 | -22.2% | ✗ MISS |
Q1 2024 | Mar 21, 2024 | $-0.13 | $-0.19 | -46.2% | ✗ MISS |
Q4 2023 | Nov 9, 2023 | $-0.10 | $-0.13 | -30.0% | ✗ MISS |
Q3 2023 | Aug 10, 2023 | $-0.12 | $-0.11 | +8.3% | ✓ BEAT |
Q2 2023 | May 11, 2023 | $-0.06 | $-0.10 | -66.7% | ✗ MISS |
Q1 2023 | Mar 16, 2023 | $0.14 | $-0.17 | -221.4% | ✗ MISS |
Q4 2022 | Nov 10, 2022 | $-0.12 | $-0.17 | -41.7% | ✗ MISS |
Q3 2022 | Aug 11, 2022 | $-0.20 | $-0.16 | +20.0% | ✓ BEAT |
Q2 2022 | May 12, 2022 | $-0.13 | $-0.17 | -30.8% | ✗ MISS |
Q1 2022 | Mar 17, 2022 | $-0.13 | $-0.06 | +53.8% | ✓ BEAT |
Q4 2021 | Nov 11, 2021 | $-0.15 | $-0.12 | +20.0% | ✓ BEAT |
Q3 2021 | Aug 12, 2021 | $-0.14 | $-0.12 | +14.3% | ✓ BEAT |
Latest News
Roth Capital Initiates Coverage On Apyx Medical with Buy Rating, Announces Price Target of $6
📈 PositiveBenzinga•Dec 16, 2025, 03:19 PM
Apyx Medical Announces Approval, Commercial Roll Out Of Apyx One Console, Single-Use Handpieces In South Korea
📈 PositiveBenzinga•Dec 3, 2025, 01:05 PM
Apyx Medical Files To Offer $100M Securities
➖ NeutralBenzinga•Dec 1, 2025, 09:17 PM
Apyx Medical shares are trading lower after the company announced a the pricing of its $10 million public offering of 2,762,431 shares at $3.62 per share.
📉 NegativeBenzinga•Nov 18, 2025, 02:09 PM
Apyx Medical Prices 2,762,431 Share Offering At $3.62/Share
➖ NeutralBenzinga•Nov 18, 2025, 12:33 PM
Apyx Medical shares are trading lower after the company announced a public offering.
📉 NegativeBenzinga•Nov 17, 2025, 09:15 PM
Apyx Medical Reveals Proposed Public Offering of Common Stock; No Size Disclosed
➖ NeutralBenzinga•Nov 17, 2025, 09:07 PM
Citizens Upgrades Apyx Medical to Market Outperform, Announces $8 Price Target
📈 PositiveBenzinga•Nov 12, 2025, 02:13 PM
Apyx Medical shares are trading higher after the company reported better-than-expected Q3 financial results and raised its FY2025 sales guidance.
📈 PositiveBenzinga•Nov 6, 2025, 03:37 PM
Apyx Medical Raises FY2025 Sales Guidance from $50.000M-$52.000M to $50.500M-$52.500M vs $50.001M Est
📈 PositiveBenzinga•Nov 6, 2025, 12:03 PM
Apyx Medical Q3 EPS $(0.05) Beats $(0.10) Estimate, Sales $12.877M Beat $12.002M Estimate
📈 PositiveBenzinga•Nov 6, 2025, 12:02 PM
Apyx Medical Submits FDA 510(k) For Device Label Expansion Of AYON Body Contouring System
📈 PositiveBenzinga•Oct 13, 2025, 12:05 PM
Apyx Medical To Host October 14 Virtual KOL Event Featuring Dr. Paul Vanek To Discuss Commercial Launch Of AYON Body Contouring System
📈 PositiveBenzinga•Sep 29, 2025, 12:14 PM
Frequently Asked Questions about APYX
What is APYX's current stock price?
Apyx Medical Corporation (APYX) is currently trading at $3.49 per share. The stock has moved -5.93% today.
What is the analyst price target for APYX?
The average analyst price target for APYX is $6.00, based on 1 analyst.
What sector is Apyx Medical Corporation in?
Apyx Medical Corporation operates in the Healthcare sector, specifically within the Medical - Devices industry. The company is traded on the NASDAQ exchange.
What is APYX's market cap?
Apyx Medical Corporation has a market capitalization of $0.13 billion, making it a small-cap company.
Does APYX pay dividends?
No, Apyx Medical Corporation does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorATOS
Atossa Therapeutics, Inc.
$0.73
Mkt Cap: $0.1B
LUCD
Lucid Diagnostics Inc.
$1.12
Mkt Cap: $0.1B
NSPR
InspireMD, Inc.
$1.99
Mkt Cap: $0.1B
PDEX
Pro-Dex, Inc.
$38.68
Mkt Cap: $0.1B
QIPT
Quipt Home Medical Corp.
$3.52
Mkt Cap: $0.2B
RCEL
AVITA Medical, Inc.
$3.46
Mkt Cap: $0.1B
RPID
Rapid Micro Biosystems, Inc.
$3.15
Mkt Cap: $0.1B
SERA
Sera Prognostics, Inc.
$3.55
Mkt Cap: $0.1B
VANI
Vivani Medical, Inc.
$1.39
Mkt Cap: $0.1B
XTNT
Xtant Medical Holdings, Inc.
$0.77
Mkt Cap: $0.1B
Explore stocks similar to APYX for comparison